131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remissionJohn M. Pagel, Dana C. Matthews, Frederick R. Appelbaum et al.|Blood|2005Cited by 157
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primatesDamian J. Green, Oliver W. Press, Yukang Lin et al.|Blood|2009Cited by 33
131I-Anti-CD45 Antibody Plus Fludarabine, Low-Dose Total Body Irradiation and Peripheral Blood Stem Cell Infusion for Elderly Patients with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).John M. Pagel, Rainer Storb, Frederick R. Appelbaum et al.|Blood|2005Cited by 25
Biodistribution of Yttrium-90–Labeled Anti-CD45 Antibody in a Nonhuman Primate ModelEneida R. Nemecek, Dana C. Matthews, Donald K. Hamlin et al.|Clinical Cancer Research|2005Cited by 23
131I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.John M. Pagel, Dana C. Matthews, Frederick R. Appelbaum et al.|Blood|2004Cited by 8